ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
momentum factor · long-only model fund

Foundry 12-Month Momentum Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FMOMHYPOTHETICAL MODEL
Since ’99
+1399%
Expense Ratio
0.29%
placeholder
Holdings
296
cap-weighted
Inception
Nov 2019
placeholder
Full Sharpe
0.48
Ann. Return (LS)
14.7%
Ann. Volatility
30.7%
Max Drawdown
-58.8%
Test Sharpe ’19–26
0.46
Test FF5 α (ann.)
20.4%
vs Fama-French 5
Test FF5 α t-stat
1.92
not significant
Monthly turnover
28%
of the long leg, per rebalance
Cumulative return (LS)
1399%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.71
what this fund holds
Long leg ann. return
17.9%
buyable, long-only
Long-short Sharpe
0.48
requires shorting
Bottom bucket ann. return
3.3%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

296 of 296 · 100.0% of book
TickerCompanySectorMarket capWeight
1MU
MICRON TECHNOLOGY INCTechnology$958.80B
14.50%
2AMD
ADVANCED MICRO DEVICES INCTechnology$808.39B
12.23%
3INTC
INTEL CORPTechnology$477.67B
7.22%
4AMAT
APPLIED MATERIALS INCTechnology$420.53B
6.36%
5CAT
CATERPILLAR INCIndustrials$405.49B
6.13%
6LRCX
LAM RESEARCH CORPTechnology$391.80B
5.93%
7KLAC
KLA CORPTechnology$277.91B
4.20%
8DELL
DELL TECHNOLOGIES INCTechnology$256.87B
3.88%
9SNDK
SANDISK CORPTechnology$200.63B
3.03%
10STX
SEAGATE TECHNOLOGY HOLDINGS PLCTechnology$176.62B
2.67%
11MRVL
MARVELL TECHNOLOGY INCTechnology$165.06B
2.50%
12WDC
WESTERN DIGITAL CORPTechnology$164.49B
2.49%
13GLW
CORNING INCTechnology$133.06B
2.01%
14VRT
VERTIV HOLDINGS COIndustrials$111.22B
1.68%
15BE
BLOOM ENERGY CORPIndustrials$61.14B
0.92%
16HPE
HEWLETT PACKARD ENTERPRISE COTechnology$60.67B
0.92%
17FIX
COMFORT SYSTEMS USA INCIndustrials$58.93B
0.89%
18LITE
LUMENTUM HOLDINGS INCTechnology$57.01B
0.86%
19COHR
COHERENT CORPTechnology$54.31B
0.82%
20CIEN
CIENA CORPTechnology$53.00B
0.80%
21ALAB
ASTERA LABS INCTechnology$52.04B
0.79%
22TER
TERADYNE INCTechnology$50.46B
0.76%
23FLEX
FLEX LTDTechnology$43.69B
0.66%
24RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
0.60%
25CRDO
CREDO TECHNOLOGY GROUP HOLDING LTDTechnology$37.80B
0.57%
26CNC
CENTENE CORPHealthcare$32.81B
0.50%
27CRS
CARPENTER TECHNOLOGY CORPIndustrials$27.71B
0.42%
28ECHO
ECHO GLOBAL LOGISTICS INCIndustrials$26.66B
0.40%
29ATI
ATI INCIndustrials$25.41B
0.38%
30ROIV
ROIVANT SCIENCES LTDHealthcare$24.82B
0.38%
31MRNA
MODERNA INCHealthcare$24.53B
0.37%
32MKSI
MKS INCTechnology$21.93B
0.33%
33ENTG
ENTEGRIS INCTechnology$21.16B
0.32%
34GH
GUARDANT HEALTH INCHealthcare$20.67B
0.31%
35MTSI
MACOM TECHNOLOGY SOLUTIONS HOLDINGS INCTechnology$20.40B
0.31%
36STRL
STERLING INFRASTRUCTURE INCIndustrials$19.59B
0.30%
37LSCC
LATTICE SEMICONDUCTOR CORPTechnology$17.16B
0.26%
38AMKR
AMKOR TECHNOLOGY INCTechnology$15.60B
0.24%
39SITM
SITIME CORPTechnology$14.65B
0.22%
40ONTO
ONTO INNOVATION INCTechnology$13.92B
0.21%
41TTMI
TTM TECHNOLOGIES INCTechnology$13.71B
0.21%
42BTSG
BRIGHTSPRING HEALTH SERVICES INCHealthcare$13.71B
0.21%
43DOCN
DIGITALOCEAN HOLDINGS INCTechnology$12.41B
0.19%
44AXSM
AXSOME THERAPEUTICS INCHealthcare$11.84B
0.18%
45SMTC
SEMTECH CORPTechnology$11.64B
0.18%
46VICR
VICOR CORPTechnology$10.83B
0.16%
47AEIS
ADVANCED ENERGY INDUSTRIES INCIndustrials$10.80B
0.16%
48ARWR
ARROWHEAD PHARMACEUTICALS INCHealthcare$10.47B
0.16%
49KRYS
KRYSTAL BIOTECH INCHealthcare$10.46B
0.16%
50HUT
HUT 8 CORPFinancial Services$10.30B
0.16%
51GSAT
GLOBALSTAR INCCommunication Services$10.20B
0.15%
52APGE
APOGEE THERAPEUTICS INCHealthcare$10.10B
0.15%
53CYTK
CYTOKINETICS INCHealthcare$9.98B
0.15%
54VSAT
VIASAT INCTechnology$9.76B
0.15%
55HL
HECLA MINING COBasic Materials$9.61B
0.15%
56KYMR
KYMERA THERAPEUTICS INCHealthcare$9.52B
0.14%
57PTGX
PROTAGONIST THERAPEUTICS INCHealthcare$9.06B
0.14%
58WULF
TERAWULF INCFinancial Services$9.00B
0.14%
59VIAV
VIAVI SOLUTIONS INCTechnology$8.93B
0.13%
60PRAX
PRAXIS PRECISION MEDICINES INCHealthcare$8.77B
0.13%
61SYRE
SPYRE THERAPEUTICS INCHealthcare$8.70B
0.13%
62POWL
POWELL INDUSTRIES INCIndustrials$8.48B
0.13%
63IMVT
IMMUNOVANT INCHealthcare$8.27B
0.13%
64FORM
FORMFACTOR INCTechnology$8.23B
0.12%
65AAOI
APPLIED OPTOELECTRONICS INCTechnology$8.22B
0.12%
66IBRX
IMMUNITYBIO INCHealthcare$8.04B
0.12%
67PL
PLANET LABS PBCIndustrials$8.01B
0.12%
68AGX
ARGAN INCIndustrials$7.73B
0.12%
69APLD
APPLIED DIGITAL CORPFinancial Services$7.37B
0.11%
70PACS
PACS GROUP INCHealthcare$7.30B
0.11%
71MIRM
MIRUM PHARMACEUTICALS INCHealthcare$7.25B
0.11%
72CIFR
CIPHER DIGITAL INCFinancial Services$7.18B
0.11%
73ENS
ENERSYSIndustrials$7.18B
0.11%
74LQDA
LIQUIDIA CORPHealthcare$7.11B
0.11%
75ECG
EVERUS CONSTRUCTION GROUP INCConsumer Cyclical$6.80B
0.10%
76PLXS
PLEXUS CORPTechnology$6.71B
0.10%
77COGT
COGENT BIOSCIENCES INCHealthcare$6.68B
0.10%
78VSXY
VICTORIA'S SECRET & COConsumer Cyclical$6.47B
0.10%
79MXL
MAXLINEAR INCTechnology$6.43B
0.10%
80CGON
CG ONCOLOGY INCHealthcare$6.34B
0.10%
81MYRG
MYR GROUP INCIndustrials$6.10B
0.09%
82LGND
LIGAND PHARMACEUTICALS INCHealthcare$6.08B
0.09%
83ERAS
ERASCA INCHealthcare$5.96B
0.09%
84GTX
GARRETT MOTION INCConsumer Cyclical$5.95B
0.09%
85TWST
TWIST BIOSCIENCE CORPHealthcare$5.84B
0.09%
86KGS
KODIAK GAS SERVICES INCEnergy$5.79B
0.09%
87ENVA
ENOVA INTERNATIONAL INCFinancial Services$5.79B
0.09%
88DNTH
DIANTHUS THERAPEUTICS INCHealthcare$5.77B
0.09%
89MRCY
MERCURY SYSTEMS INCIndustrials$5.77B
0.09%
90ORKA
ORUKA THERAPEUTICS INCHealthcare$5.59B
0.08%
91ACMR
ACM RESEARCH INCTechnology$5.56B
0.08%
92TXG
10X GENOMICS INCHealthcare$5.55B
0.08%
93SSRM
SSR MINING INCBasic Materials$5.31B
0.08%
94TVTX
TRAVERE THERAPEUTICS INCHealthcare$5.27B
0.08%
95XMTR
XOMETRY INCIndustrials$5.18B
0.08%
96VSH
VISHAY INTERTECHNOLOGY INCTechnology$5.15B
0.08%
97SPHR
SPHERE ENTERTAINMENT COCommunication Services$5.10B
0.08%
98MTRN
MATERION CORPBasic Materials$5.10B
0.08%
99KLIC
KULICKE & SOFFA INDUSTRIES INCTechnology$5.09B
0.08%
100IRDM
IRIDIUM COMMUNICATIONS INCCommunication Services$4.94B
0.07%
101DFTX
DEFINIUM THERAPEUTICS INCHealthcare$4.83B
0.07%
102VCYT
VERACYTE INCHealthcare$4.72B
0.07%
103LFST
LIFESTANCE HEALTH GROUP INCHealthcare$4.49B
0.07%
104SEI
SOLARIS ENERGY INFRASTRUCTURE INCEnergy$4.43B
0.07%
105CELC
CELCUITY INCHealthcare$4.31B
0.07%
106EWTX
EDGEWISE THERAPEUTICS INCHealthcare$4.28B
0.06%
107ACLS
AXCELIS TECHNOLOGIES INCTechnology$4.19B
0.06%
108UCTT
ULTRA CLEAN HOLDINGS INCTechnology$4.14B
0.06%
109TNGX
TANGO THERAPEUTICS INCHealthcare$4.13B
0.06%
110LION
LIONSGATE STUDIOS CORPCommunication Services$4.03B
0.06%
111DYN
DYNE THERAPEUTICS INCHealthcare$3.92B
0.06%
112LASR
NLIGHT INCTechnology$3.91B
0.06%
113DK
DELEK US HOLDINGS INCEnergy$3.88B
0.06%
114RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.06%
115CLMT
CALUMET INCEnergy$3.73B
0.06%
116ALMS
ALUMIS INCHealthcare$3.65B
0.06%
117NHC
NATIONAL HEALTHCARE CORPHealthcare$3.56B
0.05%
118GPCR
STRUCTURE THERAPEUTICS INCHealthcare$3.45B
0.05%
119RCUS
ARCUS BIOSCIENCES INCHealthcare$3.44B
0.05%
120SEDG
SOLAREDGE TECHNOLOGIES INCTechnology$3.25B
0.05%
121FSLY
FASTLY INCTechnology$3.24B
0.05%
122ELVN
ENLIVEN THERAPEUTICS INCHealthcare$3.24B
0.05%
123ONDS
ONDAS INCTechnology$3.23B
0.05%
124VECO
VEECO INSTRUMENTS INCTechnology$3.19B
0.05%
125PENG
PENGUIN SOLUTIONS INCTechnology$3.10B
0.05%
126AXTI
AXT INCTechnology$3.00B
0.05%
127MBX
MBX BIOSCIENCES INCHealthcare$2.99B
0.05%
128BELFA
BEL FUSE INCTechnology$2.91B
0.04%
129ICHR
ICHOR HOLDINGS LTDTechnology$2.88B
0.04%
130BHE
BENCHMARK ELECTRONICS INCTechnology$2.81B
0.04%
131ADEA
ADEIA INCTechnology$2.80B
0.04%
132VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.04%
133TRVI
TREVI THERAPEUTICS INCHealthcare$2.71B
0.04%
134HLIO
HELIOS TECHNOLOGIES INCIndustrials$2.68B
0.04%
135NVTS
NAVITAS SEMICONDUCTOR CORPTechnology$2.68B
0.04%
136KOD
KODIAK SCIENCES INCHealthcare$2.67B
0.04%
137FLNC
FLUENCE ENERGY INCUtilities$2.59B
0.04%
138KALU
KAISER ALUMINUM CORPBasic Materials$2.58B
0.04%
139AEHR
AEHR TEST SYSTEMSTechnology$2.55B
0.04%
140QURE
UNIQURE NVHealthcare$2.54B
0.04%
141SLS
SELLAS LIFE SCIENCES GROUP INCHealthcare$2.45B
0.04%
142COHU
COHU INCTechnology$2.41B
0.04%
143ATRO
ASTRONICS CORPIndustrials$2.41B
0.04%
144DGII
DIGI INTERNATIONAL INCTechnology$2.41B
0.04%
145ROG
ROGERS CORPTechnology$2.36B
0.04%
146OUST
OUSTER INCTechnology$2.36B
0.04%
147NKTR
NEKTAR THERAPEUTICSHealthcare$2.31B
0.03%
148BAND
BANDWIDTH INCTechnology$2.30B
0.03%
149PVLA
PALVELLA THERAPEUTICS INCHealthcare$2.26B
0.03%
150SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.03%
151DHC
DIVERSIFIED HEALTHCARE TRUSTReal Estate$2.22B
0.03%
152VSTS
VESTIS CORPIndustrials$2.18B
0.03%
153AGL
AGILON HEALTH INCHealthcare$2.17B
0.03%
154AXGN
AXOGEN INCHealthcare$2.12B
0.03%
155GRC
GORMAN RUPP COIndustrials$2.11B
0.03%
156GLUE
MONTE ROSA THERAPEUTICS INCHealthcare$2.07B
0.03%
157CDNA
CAREDX INCHealthcare$2.05B
0.03%
158PDFS
PDF SOLUTIONS INCTechnology$2.04B
0.03%
159RAPP
RAPPORT THERAPEUTICS INCHealthcare$2.04B
0.03%
160NUVB
NUVATION BIO INCHealthcare$2.03B
0.03%
161EZPW
EZCORP INCFinancial Services$1.97B
0.03%
162AMLX
AMYLYX PHARMACEUTICALS INCHealthcare$1.97B
0.03%
163ECPG
ENCORE CAPITAL GROUP INCFinancial Services$1.96B
0.03%
164ATEX
ANTERIX INCCommunication Services$1.96B
0.03%
165DMRA
DAMORA THERAPEUTICS INCHealthcare$1.94B
0.03%
166TYRA
TYRA BIOSCIENCES INCHealthcare$1.91B
0.03%
167NEO
NEOGENOMICS INCHealthcare$1.90B
0.03%
168NGL
NGL ENERGY PARTNERS LPEnergy$1.89B
0.03%
169MRVI
MARAVAI LIFESCIENCES HOLDINGS INCHealthcare$1.87B
0.03%
170ALGT
ALLEGIANT TRAVEL COIndustrials$1.86B
0.03%
171BCAX
BICARA THERAPEUTICS INCHealthcare$1.82B
0.03%
172LIND
LINDBLAD EXPEDITIONS HOLDINGS INCIndustrials$1.81B
0.03%
173STOK
STOKE THERAPEUTICS INCHealthcare$1.81B
0.03%
174HYMC
HYCROFT MINING HOLDING CORPBasic Materials$1.74B
0.03%
175BFLY
BUTTERFLY NETWORK INCHealthcare$1.73B
0.03%
176TSHA
TAYSHA GENE THERAPIES INCHealthcare$1.71B
0.03%
177ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.03%
178FTRE
FORTREA HOLDINGS INCHealthcare$1.68B
0.03%
179CMPS
COMPASS PATHWAYS PLCHealthcare$1.67B
0.03%
180TH
TARGET HOSPITALITY CORPIndustrials$1.64B
0.02%
181TE
T1 ENERGY INCIndustrials$1.63B
0.02%
182PSNL
PERSONALIS INCHealthcare$1.61B
0.02%
183PLPC
PREFORMED LINE PRODUCTS COIndustrials$1.60B
0.02%
184PUMP
PROPETRO HOLDING CORPEnergy$1.59B
0.02%
185INNV
INNOVAGE HOLDING CORPHealthcare$1.56B
0.02%
186SKYT
SKYWATER TECHNOLOGY INCTechnology$1.54B
0.02%
187SEPN
SEPTERNA INCHealthcare$1.51B
0.02%
188BRUN
BOOST RUN INCTechnology$1.50B
0.02%
189ALNT
ALLIENT INCTechnology$1.49B
0.02%
190AIP
ARTERIS INCTechnology$1.43B
0.02%
191VPG
VISHAY PRECISION GROUP INCTechnology$1.38B
0.02%
192REAL
THEREALREAL INCConsumer Cyclical$1.35B
0.02%
193BW
BABCOCK & WILCOX ENTERPRISES INCIndustrials$1.35B
0.02%
194FBYD
FALCON'S BEYOND GLOBAL INCIndustrials$1.35B
0.02%
195NWPX
NWPX INFRASTRUCTURE INCIndustrials$1.33B
0.02%
196ABSI
ABSCI CORPHealthcare$1.29B
0.02%
197INBX
INHIBRX BIOSCIENCES INCHealthcare$1.28B
0.02%
198TTI
TETRA TECHNOLOGIES INCEnergy$1.25B
0.02%
199CRVS
CORVUS PHARMACEUTICALS INCHealthcare$1.25B
0.02%
200FCEL
FUELCELL ENERGY INCIndustrials$1.25B
0.02%
201TDAY
USA TODAY CO INCConsumer Cyclical$1.25B
0.02%
202NBR
NABORS INDUSTRIES LTDEnergy$1.24B
0.02%
203DRTS
ALPHA TAU MEDICAL LTDHealthcare$1.19B
0.02%
204AVNS
AVANOS MEDICAL INCHealthcare$1.17B
0.02%
205MYE
MYERS INDUSTRIES INCConsumer Cyclical$1.17B
0.02%
206ETON
ETON PHARMACEUTICALS INCHealthcare$1.16B
0.02%
207SVRA
SAVARA INCHealthcare$1.13B
0.02%
208CAPR
CAPRICOR THERAPEUTICS INCHealthcare$1.13B
0.02%
209RHLD
RESOLUTE HOLDINGS MANAGEMENT INCIndustrials$1.10B
0.02%
210CGEM
CULLINAN THERAPEUTICS INCHealthcare$1.09B
0.02%
211JBIO
JADE BIOSCIENCES INCHealthcare$1.03B
0.02%
212AVTX
AVALO THERAPEUTICS INCHealthcare$1.02B
0.02%
213BIOA
BIOAGE LABS INCHealthcare$1.01B
0.02%
214APPS
DIGITAL TURBINE INCTechnology$1.01B
0.02%
215OLMA
OLEMA PHARMACEUTICALS INCHealthcare$1.00B
0.02%
216EVC
ENTRAVISION COMMUNICATIONS CORPCommunication Services$984M
0.01%
217ANRO
ALTO NEUROSCIENCE INCHealthcare$967M
0.01%
218LWLG
LIGHTWAVE LOGIC INCBasic Materials$960M
0.01%
219ANNX
ANNEXON INCHealthcare$950M
0.01%
220MOV
MOVADO GROUP INCConsumer Cyclical$859M
0.01%
221MITK
MITEK SYSTEMS INCTechnology$857M
0.01%
222AVR
ANTERIS TECHNOLOGIES GLOBAL CORPHealthcare$823M
0.01%
223UMAC
UNUSUAL MACHINES INCIndustrials$809M
0.01%
224UAMY
UNITED STATES ANTIMONY CORPBasic Materials$809M
0.01%
225ACRS
ACLARIS THERAPEUTICS INCHealthcare$793M
0.01%
226BLZE
BACKBLAZE INCTechnology$793M
0.01%
227DSGN
DESIGN THERAPEUTICS INCHealthcare$785M
0.01%
228MNPR
MONOPAR THERAPEUTICSHealthcare$744M
0.01%
229CLYM
CLIMB BIO INCHealthcare$727M
0.01%
230OMER
OMEROS CORPHealthcare$701M
0.01%
231LPTH
LIGHTPATH TECHNOLOGIES INCTechnology$657M
0.01%
232FEIM
FREQUENCY ELECTRONICS INCTechnology$650M
0.01%
233TCMD
TACTILE SYSTEMS TECHNOLOGY INCHealthcare$648M
0.01%
234ACHV
ACHIEVE LIFE SCIENCES INCHealthcare$644M
0.01%
235NVRI
ENVIRI CORPIndustrials$643M
0.01%
236MEC
MAYVILLE ENGINEERING COMPANY INCIndustrials$634M
0.01%
237FET
FORUM ENERGY TECHNOLOGIES INCEnergy$593M
0.01%
238STTK
SHATTUCK LABS INCHealthcare$577M
0.01%
239FDMT
4D MOLECULAR THERAPEUTICS INCHealthcare$575M
0.01%
240IMMX
IMMIX BIOPHARMA INCHealthcare$558M
0.01%
241RLMD
RELMADA THERAPEUTICS INCHealthcare$550M
0.01%
242ELA
ENVELA CORPConsumer Cyclical$547M
0.01%
243PKOH
PARK OHIO HOLDINGS CORPIndustrials$544M
0.01%
244XMAX
XMAX INCConsumer Cyclical$541M
0.01%
245CTNM
CONTINEUM THERAPEUTICS INCHealthcare$532M
0.01%
246MEI
METHODE ELECTRONICS INCTechnology$532M
0.01%
247ORN
ORION GROUP HOLDINGS INCIndustrials$518M
0.01%
248ZURA
ZURA BIO LTDHealthcare$518M
0.01%
249NVCT
NUVECTIS PHARMA INCHealthcare$508M
0.01%
250KYTX
KYVERNA THERAPEUTICS INCHealthcare$453M
0.01%
251ALTO
ALTO INGREDIENTS INCBasic Materials$453M
0.01%
252PBYI
PUMA BIOTECHNOLOGY INCHealthcare$434M
0.01%
253TENX
TENAX THERAPEUTICS INCHealthcare$420M
0.01%
254FLXS
FLEXSTEEL INDUSTRIES INCConsumer Cyclical$391M
0.01%
255STRO
SUTRO BIOPHARMA INCHealthcare$391M
0.01%
256ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.01%
257ELMD
ELECTROMED INCHealthcare$349M
0.01%
258MRAM
EVERSPIN TECHNOLOGIES INCTechnology$341M
0.01%
259MPTI
M-TRON INDUSTRIES INCTechnology$328M
0.00%
260TWIN
TWIN DISC INCIndustrials$326M
0.00%
261VELO
VELO3D INCTechnology$316M
0.00%
262OSS
ONE STOP SYSTEMS INCTechnology$313M
0.00%
263OPTX
SYNTEC OPTICS HOLDINGS INCTechnology$302M
0.00%
264SVCO
SILVACO GROUP INCTechnology$260M
0.00%
265QTTB
Q32 BIO INCHealthcare$255M
0.00%
266SRZN
SURROZEN INCHealthcare$255M
0.00%
267ASYS
AMTECH SYSTEMS INCTechnology$242M
0.00%
268ARTV
ARTIVA BIOTHERAPEUTICS INCHealthcare$241M
0.00%
269QUIK
QUICKLOGIC CORPTechnology$237M
0.00%
270RDNW
RIDENOW GROUP INCConsumer Cyclical$229M
0.00%
271ALOT
ASTRONOVA INCTechnology$222M
0.00%
272KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.00%
273BDSX
BIODESIX INCHealthcare$204M
0.00%
274FOCL
FOCAL INCHealthcare$204M
0.00%
275INTT
INTEST CORPTechnology$169M
0.00%
276AMPG
AMPLITECH GROUP INCTechnology$168M
0.00%
277KORE
KORE GROUP HOLDINGS INCCommunication Services$163M
0.00%
278AP
AMPCO PITTSBURGH CORPIndustrials$156M
0.00%
279RFIL
R F INDUSTRIES LTDIndustrials$143M
0.00%
280SIF
SIFCO INDUSTRIES INCIndustrials$141M
0.00%
281OCC
OPTICAL CABLE CORPTechnology$130M
0.00%
282VTVT
VTV THERAPEUTICS INCHealthcare$130M
0.00%
283VATE
INNOVATE CORPIndustrials$123M
0.00%
284SPRB
SPRUCE BIOSCIENCES INCHealthcare$120M
0.00%
285WYY
WIDEPOINT CORPTechnology$115M
0.00%
286TRT
TRIO-TECH INTERNATIONALTechnology$103M
0.00%
287CHRN
CHRONOSCALE CORPIndustrials$94M
0.00%
288RLYB
RALLYBIO CORPHealthcare$87M
0.00%
289INTG
INTERGROUP CORPConsumer Cyclical$84M
0.00%
290NRXS
NEURAXIS INCHealthcare$84M
0.00%
291VNCE
VINCE HOLDING CORPConsumer Cyclical$83M
0.00%
292ROLR
HIGH ROLLER TECHNOLOGIES INCConsumer Cyclical$76M
0.00%
293BNAI
BRAND ENGAGEMENT NETWORK INCTechnology$76M
0.00%
294BODI
BEACHBODY COMPANY INCCommunication Services$75M
0.00%
295LONA
LEONABIO INCHealthcare$68M
0.00%
296EDSA
EDESA BIOTECH INCHealthcare$59M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $6.61T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

10 sectors
Technology
78.0%
Industrials
12.5%
Healthcare
7.2%
Financial Services
0.7%
Communication Services
0.4%
Basic Materials
0.4%
Consumer Cyclical
0.4%
Energy
0.4%
Utilities
0.0%
Real Estate
0.0%

Portfolio Style

Size × value map of the long-leg book

296 classified
Value
Blend
Growth
Large
Mid
Small
<1%1
28%19
65%66
<1%10
1%39
2%62
<1%15
<1%25
<1%22

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 98% toward Large, 84% toward Growth. +2% unclassified (37 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt98% → Large
SmallLarge
Value ↔ growth tilt84% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
4
Failed
1
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    51.7%
    Margin
    -26.7%
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.7 (95% CI 1.1-2.4)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
16.0%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.67x
within
parametric
1.57x
within
cornish fisher
1.60x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 1993
Entirely since publication
All 331 months of our record post-date the 1993 paper.
Sharpe 0.4814.7% p.a.January 1999July 2026

There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
92%
24 of 26 3-year windows made money
Worst window
-0.26
Sharpe, January 2009 – December 2011
January 1999July 2026
Median Sharpe
0.45
Dispersion
0.37
Best window
1.41

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.48.0%26.3%
3 yearsp.a.36.5%21.9%
5 yearsp.a.21.2%18.8%
10 yearsp.a.22.6%11.1%
Since inceptionp.a.15.8%10.3%
Calendar years
YearLong legLong-short
20267 mo34.8%40.2%
20259.2%-16.7%
202464.3%49.5%
202330.5%-19.4%
2022-14.1%56.4%
20211.4%-20.2%
202059.0%21.9%
201929.8%-2.0%
20183.4%23.4%
201726.7%13.5%
20165.4%-17.6%
20153.8%40.4%
201414.1%4.3%
201342.5%-0.4%
201225.8%8.2%
2011-7.5%19.9%
201033.1%10.7%
200917.2%-49.1%
2008-39.4%41.9%
200736.3%68.4%
20063.2%-12.5%
200522.3%25.0%
20044.8%-15.0%
200357.7%-5.6%
2002-14.9%41.0%
2001-6.0%-1.1%
2000-22.7%-2.4%
1999124.3%103.7%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FMOM
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.29% (placeholder)
Inception2019-11-21 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$6.61T

Methodology

The Foundry 12-Month Momentum Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a 12-Month Momentum signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.